RTW Investments’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
BI
APM
LCM
SCM
RTW Investments's IMUX Position: Q3 2025 in Review
RTW Investments sold out of Immunic (IMUX) in Q3 2025, closing a stake of 40,211 shares — an estimated $280K sold.
RTW Investments first reported a position in IMUX in Q3 2020 and held it in 19 quarters. The position peaked at $30.6M in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.
- RTW Investments reported no remaining Immunic position as of Q3 2025 after selling out during the quarter.
- RTW Investments sold 40,211 Immunic shares in Q3 2025, an estimated $280K.
- RTW Investments first reported a position in Immunic in Q3 2020 and held it in 19 quarters.
- RTW Investments's Immunic position peaked at $30.6M in Q1 2022.
- 59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.
Based on RTW Investments's 13F filing for Q3 2025, filed 14 Nov 2025.